|
2024
|
P/S
|
pharmaceutical products for human use for the treatment of rare diseases; diagnostic preparations... |
|
|
Invention
|
Polymorphic forms and formulations of leriglitazone. This disclosure provides crystalline forms o... |
|
2023
|
Invention
|
Optimized dosing of leriglitazone. The present disclosure provides methods of treating a disease ... |
|
|
Invention
|
Use of 5-[[4-[2-[5-acetylpyridin-2-yl]ethoxy]benzyl]-1,3-thiazolidine-2,4-dione and its salts.
T... |
|
2021
|
Invention
|
Heteroaryl compounds and their use. 3, and n are as set forth in the specification, as well as to... |
|
|
Invention
|
Process for preparing 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]-methyl]-2,4-thiazol... |
|
|
Invention
|
Leriglitazone for treating lung inflammation and interstitial lung disease.
The present disclosu... |
|
|
Invention
|
Leriglitazone for treating lung inflammation and interstitial lung disease. The present disclosur... |
|
|
P/S
|
Pharmaceuticals, namely pharmaceutical preparations for the treatment of genetic disorders, namel... |
|
|
P/S
|
Pharmaceutical products for the treatment of central nervous system diseases; medicines for medic... |
|
|
P/S
|
Pharmaceutical preparations for human use for the treatment of central nervous system (CNS) disea... |
|
|
P/S
|
Pharmaceutical products; medicines for medical use; drugs;
pharmaceutical preparations for treat... |
|
2020
|
P/S
|
Pharmaceuticals; Medicines for human purposes; Pharmaceutical drugs; Pharmaceutical preparations ... |
|
2019
|
Invention
|
Method of administering a therapeutically effective amount of 5-[[4-[2-[5-(1-hydroxyethyl)pyridin... |
|
|
Invention
|
5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione and its... |
|
|
Invention
|
Use of 5-[[4-[2-[5-acetylpyridin-2-yl]ethoxy]benzyl]-1,3-thiazolidine-2,4-dione and its salts. Th... |
|
2018
|
Invention
|
2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders.
The pres... |
|
2017
|
Invention
|
Heteroaryl compounds and their use. The application is directed to compounds of formula (I): and ... |
|
|
Invention
|
Isoquinoline compounds, methods for their preparation, and therapeutic uses thereof in conditions... |
|
|
Invention
|
Process for preparing 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazoli... |
|
|
Invention
|
5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3- thiazolidine-2,4-dione for tr... |
|
|
Invention
|
5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine- 2,4-dione for tr... |
|
|
Invention
|
2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders. The prese... |
|
2016
|
Invention
|
Heteroarylaminoisoquinolines, methods for their preparation and therapeutic uses thereof. The app... |
|
2015
|
P/S
|
[ pharmaceutical products for human use for the treatment of rare diseases; diagnostic preparatio... |
|
|
P/S
|
Pharmaceutical products for human use; Diagnostic products
for medical use; all excluding pharma... |
|
|
Invention
|
2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders. There is ... |
|
2014
|
Invention
|
Di(hetero)arylamides and sulfonamides, methods for their preparation and therapeutic uses thereof... |
|
2013
|
P/S
|
Pharmaceuticals for human use; Diagnostic preparations for medical purposes; All the aforesaid no... |
|
2012
|
P/S
|
Pharmaceutical preparations for human use; Diagnostic preparations for medical purposes; All the ... |
